Edwards Lifesciences (EW) Offers Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
- Oil prices settle at pre-Iran war levels as crude output grows
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
Cowen Reiterates Outperform on Edwards Lifesciences (EW)
December 10, 2018 8:18 AM ESTCowen analyst, Joshua Jennings, reiterated an Outperform rating and $190.00 price target on Edwards Lifesciences (NYSE: EW). Jennings views the 4Q18 setup favorably and expects EW to accelerate TAVR sales growth in 2019. Cowen thinks last weeks investor conference justifies bullishness about the growth... More
Edwards Lifesciences (EW) PT Raised to $175 at RBC Capital
December 6, 2018 7:15 AM ESTRBC Capital analyst Glenn Novarro raised the price target on Edwards Lifesciences (NYSE: EW) to $175.00 (from $153.00) while maintaining a Outperform rating.
The firm is increasing EPS estimates for 2019 and 2020 on the basis of higher gross margin and lower tax rate assumptions.
... More